NCT01478581View on ClinicalTrials.gov

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

PCI-32765

DRUG

Dexamethasone

Trial Locations (11)

10029

SITE-10, New York

10065

SITE-3, New York

21287

SITE-5, Baltimore

37203

SITE-1, Nashville

48109

SITE-8, Ann Arbor

63110

SITE-2, St Louis

75390

SITE-11, Dallas

92093

SITE-13, La Jolla

98109

SITE-9, Seattle

02215

SITE-4, Boston

07601

SITE-6, Hackensack

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY